首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Expert review of cardiovascular therapy

缩写:

ISSN:1477-9072

e-ISSN:1744-8344

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2566
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Andrea Romarheim,Sverre Lehmann,Bjørn Bjorvatn et al. Andrea Romarheim et al.
Introduction: Obstructive sleep apnea (OSA) - characterized by recurrent upper airway obstruction during sleep - remains underdiagnosed and undertreated. Affecting nearly one billion adults globally, OSA is especially pre...
Ilaria Maria Palumbo,Tommaso Bucci,Danilo Menichelli et al. Ilaria Maria Palumbo et al.
Introduction: Life expectancy is rising globally, leading to an expected increase in age-related cardiovascular diseases. Managing cardiovascular disease in older adults is particularly challenging, as these patients ofte...
Michail Penteris,Konstantinos Lampropoulos Michail Penteris
Introduction: To perform a systematic review and meta-analysis to compare the safety, early and late mortality, morbidity and long-term function of the tricuspid valve (TV) following tricuspid transcatheter edge-to-edge r...
Tamer Jamal,Elizabeth H Stephens,Nathan Taggart et al. Tamer Jamal et al.
Introduction: Ebstein anomaly (EA) is a rare congenital heart defect with a broad spectrum of severity - both anatomically and clinically. Treatment options have evolved and hence the rationale for this review. ...
Vincenzo De Sio,Felice Gragnano,Arturo Cesaro et al. Vincenzo De Sio et al.
Introduction: Cangrelor is the only parenteral P2Y12 receptor antagonist currently recommended for the prevention of periprocedural thrombotic complications in P2Y12 inhibitor-naïve patients undergoing percutaneous coron...
Göran Walldius Göran Walldius
Introduction: Hypercholesterolemia and other dyslipidemias are common risk factors for cardiovascular diseases (CVD) and development of atherosclerosis. International guidelines recommend LDL-C, non-HDL-C and apoB under s...